Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Hugh presenting To some of Canada's top healthcare leaders
View:
Post by jopatclo on Jun 24, 2024 6:52am

Hugh presenting To some of Canada's top healthcare leaders

Good comment on post Miro TOMORROWS This is what Ventripoint's CEO Hugh MacNaught will be presenting on June 25th at The Data Effect in Vancouver, to some of Canada's top health care leaders.
Subscribe to newsletter

A.I. is really impacting our health care system.
The idea of being able to give almost any patient access to a heart scan in the fraction of the time and cost of an MRI, using what amounts to ultrasounds that use A.I. to create high-fidelity images, is a remarkable advancement.

This is what Ventripoint's CEO Hugh MacNaught will be presenting on June 25th at The Data Effect in Vancouver, to some of Canada's top health care leaders.

It's a made-in-Canada health-tech breakthrough, that leading hospitals are using.
During the past several months Ventripoint has released VMS+ V3.2 and submitted V4.0 to FDA for 510(k) clearance. We are now preparing for product launch and market entry for what we believe is a product that promises true benefits for patients, clinicians and healthcare providers.
Comment by jopatclo on Jun 24, 2024 9:39am
good open TSX-V 0.22   and at any time news from the FDA V4.0 We are now preparing for product launch and market entry for what we believe is a product that promises true benefits for patients, clinicians and healthcare providers. In the post on Linkein Hugh MacNaught President and CEO at Ventripoint Diagnostics Ltd. 5 days ago During the past several months Ventripoint has released VMS+ ...more  
VentriPoint Diagnostics Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities